HP Arize 3D Orthotics for Planar Fasciitis
Comparing Efficacy Between Traditionally Fabricated Foot Orthotics and the HP Arize 3D Printed Foot Orthotics
1 other identifier
interventional
30
1 country
1
Brief Summary
Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2023
CompletedFirst Submitted
Initial submission to the registry
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
February 5, 2026
February 1, 2026
3.4 years
January 20, 2023
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-reported compliance and satisfaction with orthotics.
Patient-reported compliance with traditionally fabricated or 3D-printed orthotics will be assessed at 4 weeks and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey includes questions related to how often the patient wore their orthotics, the ease of the process, and fit and feel of the orthotics, and any experienced side effects. This survey was developed by the research team and includes subjective responses to questions; there is no score associated with this assessment.
8 weeks
Secondary Outcomes (1)
Patient-reported secondary site pain following implementation of orthotics.
8 weeks
Study Arms (2)
HP Arize 3D-Printed Orthotics
EXPERIMENTALPatients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Traditional Orthotics
ACTIVE COMPARATORPatients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.
Interventions
Custom 3D-printed orthotics manufactured by HP.
Traditionally fabricated custom orthotics manufactured by a local supplier.
Eligibility Criteria
You may qualify if:
- At least 18 years of age
- Diagnosis of plantar fasciitis
- Access to methods of electronic communication (i.e., email)
You may not qualify if:
- Previously prescribed and/or used orthotic inserts
- Requires additional bracing of the lower leg
- Diagnosis of neuropathy, acute fracture, or stress fracture
- Pregnant women
- Non-English speakers
- Medicare patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prisma Health-Midlandslead
- Hewlett-Packard (HP)collaborator
Study Sites (1)
Prisma Health - Midlands
Lexington, South Carolina, 29072, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2023
First Posted
January 31, 2023
Study Start
January 19, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share